|Bid||131.21 x 2900|
|Ask||132.12 x 1200|
|Day's range||131.00 - 147.32|
|52-week range||19.31 - 189.26|
|Beta (5Y monthly)||1.50|
|PE ratio (TTM)||N/A|
|Earnings date||05-May-2021 - 10-May-2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||168.85|
Arena's (ARNA) mid-stage study evaluating olorinab in patients with abdominal pain due to irritable bowel syndrome fails to meet primary endpoint.
Public health experts have dismissed concerns about J&J' vaccine and stressed its importance.
Johnson & Johnson’s single-dose COVID-19 vaccine is ‘absolutely’ a game changer and will help ensure Americans are vaccinated at a faster pace, according to Dr. Sejal Hathi, physician and clinical fellow at Massachusetts General Hospital.